Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.
Deheuninck J, Goormachtigh G, Foveau B, Ji Z, Leroy C, Ancot F, Villeret V, Tulasne D, Fafeur V.
Cell Signal. 2009 Sep;21(9):1455-63. Epub 2009 May 18.
Related citations
Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates.
Ng C, Jackson RA, Buschdorf JP, Sun Q, Guy GR, Sivaraman J.
EMBO J. 2008 Mar 5;27(5):804-16. Epub 2008 Feb 14.
Somatic mutations lead to an oncogenic deletion of met in lung cancer.
Kong-Beltran M, Seshagiri S, Zha J, Zhu W, Bhawe K, Mendoza N, Holcomb T, Pujara K, Stinson J, Fu L, Severin C, Rangell L, Schwall R, Amler L, Wickramasinghe D, Yauch R.
Cancer Res. 2006 Jan 1;66(1):283-9.
A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M.
J Biol Chem. 2004 Jul 9;279(28):29565-71. Epub 2004 Apr 29.
The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.
Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S.
Nature. 2002 Mar 14;416(6877):187-90.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on